GondolaBio
CA - Palo AltoBiotechnology
Focus: GondolaBio is a 5,000+ employee biotech company headquartered in Palo Alto, focused on therapeutics for genetic diseases in rare diseases and oncology. Founded in 2024, the company operates at scale with an active pipeline in early-to-mid clinical development.
Profile data last refreshed 46m ago · AI intelligence enriched 3w ago
Employees
5000+
Open Jobs
15
Should You Work at GondolaBio?
AI assessmentGondolaBio presents a growth-stage opportunity with recent clinical validation, but unproven financial fundamentals and opaque pipeline depth warrant due diligence before commitment.
Why Work Here
- Recent Phase 2a success with PORT-77 demonstrating 79% plasma protoporphyrin IX reduction in erythropoietic protoporphyria provides near-term clinical validation and potential market differentiation.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for GondolaBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.